JP2008509921A5 - - Google Patents

Download PDF

Info

Publication number
JP2008509921A5
JP2008509921A5 JP2007525779A JP2007525779A JP2008509921A5 JP 2008509921 A5 JP2008509921 A5 JP 2008509921A5 JP 2007525779 A JP2007525779 A JP 2007525779A JP 2007525779 A JP2007525779 A JP 2007525779A JP 2008509921 A5 JP2008509921 A5 JP 2008509921A5
Authority
JP
Japan
Prior art keywords
compound
fragment
lox
pharmaceutical composition
heat shock
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007525779A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008509921A (ja
Filing date
Publication date
Priority claimed from US10/917,326 external-priority patent/US7575738B2/en
Application filed filed Critical
Publication of JP2008509921A publication Critical patent/JP2008509921A/ja
Publication of JP2008509921A5 publication Critical patent/JP2008509921A5/ja
Pending legal-status Critical Current

Links

JP2007525779A 2004-08-13 2005-08-11 内皮特異的な生体内伝達のターゲティング剤としての熱ショックタンパク質 Pending JP2008509921A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/917,326 US7575738B2 (en) 2004-08-13 2004-08-13 Heat shock protein as a targeting agent for endothelium-specific in vivo transduction
PCT/US2005/028491 WO2006020743A2 (en) 2004-08-13 2005-08-11 Heat shock protein as a targeting agent for endothelium-specific in vivo transduction

Publications (2)

Publication Number Publication Date
JP2008509921A JP2008509921A (ja) 2008-04-03
JP2008509921A5 true JP2008509921A5 (https=) 2008-09-18

Family

ID=35431037

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007525779A Pending JP2008509921A (ja) 2004-08-13 2005-08-11 内皮特異的な生体内伝達のターゲティング剤としての熱ショックタンパク質

Country Status (5)

Country Link
US (1) US7575738B2 (https=)
EP (1) EP1776144A2 (https=)
JP (1) JP2008509921A (https=)
CN (1) CN101039702A (https=)
WO (1) WO2006020743A2 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0610395D0 (en) * 2006-05-25 2006-07-05 Ge Healthcare Ltd Novel imaging agents
GB0811856D0 (en) 2008-06-27 2008-07-30 Ucl Business Plc Magnetic microbubbles, methods of preparing them and their uses
US8440167B2 (en) * 2008-10-27 2013-05-14 University Of Virginia Patent Foundation Multimodal imaging of atherosclerotic plaque targeted to LOX-1
WO2011045734A1 (en) 2009-10-16 2011-04-21 Koninklijke Philips Electronics N.V. Photoacoustic contrast agent based active ultrasound imaging
GB201102189D0 (en) * 2011-02-08 2011-03-23 King S College London Materials and methods relating to cardiovascular imaging
JP6410339B2 (ja) * 2013-03-25 2018-10-24 国立大学法人千葉大学 放射性核種標識オクトレオチド誘導体

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5175343A (en) * 1985-01-14 1992-12-29 Neorx Corporation Metal radionuclide labeled proteins for diagnosis and therapy
US4752141A (en) 1985-10-25 1988-06-21 Luxtron Corporation Fiberoptic sensing of temperature and/or other physical parameters
US4986671A (en) 1989-04-12 1991-01-22 Luxtron Corporation Three-parameter optical fiber sensor and system
US5275594A (en) 1990-11-09 1994-01-04 C. R. Bard, Inc. Angioplasty system having means for identification of atherosclerotic plaque
US5217456A (en) 1992-02-24 1993-06-08 Pdt Cardiovascular, Inc. Device and method for intra-vascular optical radial imaging
WO1999048914A1 (en) * 1998-03-26 1999-09-30 The University Of New Mexico Methods for using heat shock proteins
DK1133517T3 (da) * 1998-11-24 2009-11-23 Bristol Myers Squibb Co Intranuklear målrettet transport af forbindelser ved hjælp af 70 kd varmeshock-protein
AU2002254000A1 (en) 2001-02-23 2002-09-12 Bristol-Myers Squibb Pharma Company Labeled macrophage scavenger receptor antagonists for imaging atherosclerosis and vulnerable plaque
US20040071656A1 (en) * 2001-12-26 2004-04-15 Felix Wieland Modulation of heat-shock-protein-based immunotherapies
US20050089471A1 (en) * 2003-10-24 2005-04-28 Johnson Bruce F. Labeled ligands for lectin-like oxidized low-density lipoprotein receptor (LOX-1)

Similar Documents

Publication Publication Date Title
CN111263747B (zh) 双官能螯合物的药代动力学增强及其用途
EA201001625A1 (ru) Человеческие сывороточные альбуминовые линкеры и их конъюгаты
CA2955438C (en) DEXTRANE CONJUGATES TO TARGET MACROPHAGES AND OTHER CELLS EXPRESSING THE D-MANBOSE BINDING TYPE C LECTIN RECEPTOR
KR102414718B1 (ko) 암의 진단 및 치료를 위한 조성물 및 방법
EA200971130A1 (ru) Агонисты гуанилатциклазы, пригодные для лечения желудочно-кишечных нарушений, воспаления, рака и других заболеваний
JP2009511583A5 (https=)
JP2009511521A5 (https=)
JP2010531363A5 (https=)
CN110891614A (zh) Igf-1r单克隆抗体及其用途
ATE507845T1 (de) Polyacetal-arzneimittelkonjugate als freisetzungssystem
JP2016534990A5 (https=)
CA2452923A1 (en) Peptide-based compounds for targeting integrin receptors
JP2012510499A5 (https=)
WO2008047241A3 (en) Modified corticotropin releasing factor peptides and uses thereof
JP2009521206A5 (https=)
JP2010522141A5 (https=)
US11414455B2 (en) Toll-like receptor 2 ligands and methods of making and using thereof
BRPI0414864A (pt) composição farmacêutica multiparticulada compreendendo ácido micofenólico ou micofenolato de sódio e combinação com rapamicida
CN108697729A (zh) 新型GLUT抑制剂rapaglutin及其用途
JP2008509921A5 (https=)
WO2007038346A3 (en) Multiphoton in vivo flow cytometry method and device
CN106459126B (zh) 新型葡萄糖衍生物、及使用该衍生物的细胞成像方法及显像剂
EP2243496A3 (en) Contrast agents to target extracellular matrix
TN2009000100A1 (en) Silicon derivatives for pet imaging
TW200637875A (en) Cytotoxicity mediation of cells evidencing surface expression of CD63